Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BAYA NYSE:FVR NASDAQ:OACC NASDAQ:PLMK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBAYABayview Acquisition$11.67+4.9%$11.16$10.30▼$11.99$60.51M-0.06243 shs400 shsFVRFrontView REIT$12.10+1.5%$11.93$10.61▼$19.76$227.50MN/A164,061 shs248,891 shsOACCOaktree Acquisition Corp. III Life Sciences$10.47$10.48$9.95▼$10.85$234.79MN/A18,909 shs26,150 shsPLMKPlum Acquisition Corp. IV$10.29+0.1%$10.27$9.94▼$10.34$249.46MN/A16,261 shs75,044 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBAYABayview Acquisition+5.14%+1.48%+3.92%+6.53%+12.97%FVRFrontView REIT+1.65%+0.33%+2.89%+4.54%+1,209,999,900.00%OACCOaktree Acquisition Corp. III Life Sciences0.00%0.00%+0.58%+0.19%+1,046,999,900.00%PLMKPlum Acquisition Corp. IV0.00%-0.19%+0.39%+1.58%+1,028,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBAYABayview AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AFVRFrontView REIT1.1504 of 5 stars2.10.02.50.01.60.00.6OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/AN/AN/APLMKPlum Acquisition Corp. IVN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBAYABayview Acquisition 0.00N/AN/AN/AFVRFrontView REIT 2.20Hold$15.1024.79% UpsideOACCOaktree Acquisition Corp. III Life Sciences 0.00N/AN/AN/APLMKPlum Acquisition Corp. IV 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BAYA, PLMK, OACC, and FVR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/11/2025FVRFrontView REITMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight$13.506/17/2025FVRFrontView REITBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underperform$15.00 ➝ $11.006/17/2025FVRFrontView REITJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$14.00 ➝ $12.006/10/2025FVRFrontView REITJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$15.00 ➝ $14.00(Data available from 8/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBAYABayview AcquisitionN/AN/AN/AN/AN/AN/AFVRFrontView REIT$66.68M3.46$0.51 per share23.67$30.23 per share0.40OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/APLMKPlum Acquisition Corp. IVN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBAYABayview AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AFVRFrontView REIT-$22.21MN/A0.0010.17N/AN/AN/AN/A8/13/2025 (Estimated)OACCOaktree Acquisition Corp. III Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/APLMKPlum Acquisition Corp. IVN/AN/A0.00∞N/AN/AN/AN/AN/ALatest BAYA, PLMK, OACC, and FVR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025FVRFrontView REIT$0.31N/AN/AN/A$16.20 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBAYABayview AcquisitionN/AN/AN/AN/AN/AFVRFrontView REIT$0.867.11%N/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/APLMKPlum Acquisition Corp. IVN/AN/AN/AN/AN/ALatest BAYA, PLMK, OACC, and FVR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/15/2025FVRFrontView REITquarterly$0.21507.4%6/30/20256/30/20257/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBAYABayview AcquisitionN/AN/AN/AFVRFrontView REIT0.600.170.17OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/APLMKPlum Acquisition Corp. IVN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBAYABayview AcquisitionN/AFVRFrontView REITN/AOACCOaktree Acquisition Corp. III Life SciencesN/APLMKPlum Acquisition Corp. IVN/AInsider OwnershipCompanyInsider OwnershipBAYABayview Acquisition31.80%FVRFrontView REIT4.30%OACCOaktree Acquisition Corp. III Life SciencesN/APLMKPlum Acquisition Corp. IVN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBAYABayview AcquisitionN/A5.44 million3.71 millionN/AFVRFrontView REITN/A19.09 million18.27 millionN/AOACCOaktree Acquisition Corp. III Life SciencesN/A22.42 millionN/AN/APLMKPlum Acquisition Corp. IV224.24 millionN/AN/ABAYA, PLMK, OACC, and FVR HeadlinesRecent News About These CompaniesPicton Mahoney Asset Management Makes New $1.51 Million Investment in Plum Acquisition Corp. IV (NASDAQ:PLMK)July 30, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBAYA, PLMK, OACC, and FVR Company DescriptionsBayview Acquisition NASDAQ:BAYA$11.67 +0.55 (+4.95%) Closing price 08/6/2025 07:00 AM EasternExtended Trading$11.67 0.00 (0.00%) As of 08/6/2025 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bayview Acquisition Corp is a blank check company. It formed for the purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Bayview Acquisition Corp is based in Cayman Islands.FrontView REIT NYSE:FVR$12.10 +0.18 (+1.51%) Closing price 08/6/2025 03:59 PM EasternExtended Trading$12.08 -0.02 (-0.17%) As of 08/6/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FrontView REIT specializes in real estate investing.Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC$10.47 0.00 (0.00%) As of 08/5/2025 02:14 PM EasternOaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.Plum Acquisition Corp. IV NASDAQ:PLMK$10.29 +0.01 (+0.10%) As of 08/5/2025 11:32 AM EasternPlum Acquisition Corp. IV is a blank check company, which was established for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on June 10, 2024 and is headquartered in San Francisco, CA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Joby Deal Gives Blade New Direction, But Stock Lacks Lift How DigitalOcean's Focus Is Fueling Explosive Growth Disney’s Iger-Led Turnaround Gains Traction Can Celsius Stock Keep Its Momentum Going Any Longer? AMD’s Results Sparked a Sell-Off—But That’s Your Buy Signal Rivian Takes Earnings Hit—R2 Could Be the Stock's 2026 Lifeline Does Broadcom Have a VMware Problem? Goldman Eyes Upside in NTNX RSI Stock Soars 22% On Q2 Blowout—Will PENN Match the Momentum? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
